The Patent Finder

Morishita Jintan Co., Ltd.

10 patents currently held · Updated Nov 21, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Dec 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 16, 2026
    The maintenance fee for Method for inhibition of blood phosphorus level elevation (US 9,056,122) comes due Dec 16, 2026. Unpaid by Jun 16, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,842,384Heat resistant capsule and process for producing the same
In force
 · USPTO record
In forceUSPTO record
US 9,056,122Method for inhibition of blood phosphorus level elevation
In force
 · USPTO record
In forceUSPTO record
US 8,741,364Method of improving fat metabolism
In force
 · USPTO record
In forceUSPTO record
US 8,354,113Gene expressing a bifidobacterium surface-presented fusion protein
In force
 · USPTO record
In forceUSPTO record
US 9,510,609Seamless capsule and manufacturing method therefor
In force
 · USPTO record
In forceUSPTO record
US 8,747,893Capsule which disintegrates specifically in the large intestine
In force
 · USPTO record
In forceUSPTO record
US 9,669,063Composition for prevention, amelioration or treatment of metabolic syndrome
In force
 · USPTO record
In forceUSPTO record
US 12,302,935Three-layered capsule constructed with non-hydrogenated oil and production thereof
In force
 · USPTO record
In forceUSPTO record
US 12,434,215Microcapsule Production Method
In force
 · High confidence
In forceHigh confidence
US 12,514,824Delayed Disintegration-Type Capsule and Method for Producing Same
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 10: 1 patent in force now held by others · 7 lapsed for an unpaid fee · 16 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 3 abandoned · 11 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited